Elise Tu

Senior Clinical Project Coord

Elise is a Clinical Project Coordinator at the Kirby Institute, UNSW Sydney with a PhD in microbiology. She works on various studies and more recently the TEMPO study, which compares new testing strategies to enhance HCV treatment uptake among people with HCV and recent injecting drug use attending NSP services. Prior to this, she was working on the organ and tissue donor screening program for BBVs at the Prince of Wales Hospital. 

 

publications

Journal articles
add
Matthews GV; Bhagani S; Van der Valk M; Rockstroh J; Feld JJ; Rauch A; Thurnheer C; Bruneau J; Kim A; Hellard M; Shaw D; Gane E; Nelson M; Ingiliz P; Applegate TL; Grebely J; Marks P; Martinello M; Petoumenos K; Dore GJ; Marks P; Applegate T; Amjad S; Tu E; Tamaddoni M; Thurnheer MC; Gilleece Y; Fraser C; Moriggia A; Lutz T; Moon J; Read P; Kim AY; Ustianowski A; Cordes C; Sasadeusz J; Hull M; Braun D, 2021, 'Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection', Journal of Hepatology, vol. 75, pp. 829 - 839, http://dx.doi.org/10.1016/j.jhep.2021.04.056
2021
Martinello M; Orkin C; Cooke G; Bhagani S; Gane E; Kulasegaram R; Shaw D; Tu E; Petoumenos K; Marks P; Grebely J; Dore GJ; Nelson M; Matthews GV, 2020, 'Short-Duration Pan-Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection', Hepatology, vol. 72, pp. 7 - 18, http://dx.doi.org/10.1002/hep.31003
2020
Martinello M; Orkin C; Cooke G; Bhagani S; Gane E; Kulasegaram R; Shaw D; Tu E; Filep E; Petoumenos K; Marks P; Applegate T; Grebely J; Dore G; Nelson M; Matthews G, 2019, 'Shortened duration pan-genotypic therapy with glecaprevir-pibrentasvir for six weeks among people with acute and recent HCV infection', JOURNAL OF HEPATOLOGY, vol. 70, pp. E231 - E231, http://dx.doi.org/10.1016/S0618-8278(19)30432-3
2019
Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Alberto Arnaiz J; Cooper D; Rockstroh JK; Mallon P; Emery S; Fisher M; Rockstroh J; Stellbrink J; Merlin K; Yeung J; Fsadni B; Marks K; Suzuki K; Rismanto N; Salomon H; Rubio AE; Chibo D; Birch C; Swenson L; Chan D; Berg T; Obermeier M; Schuelter E; Aragon SS; Luebke N; Coughlan S; Dean J; Iwatani Y; Teran GR; Avila S; Sirivichayakul S; Naphassanant M; Ubolyam S; Kaye S; Land S; Walker S; Haubrich R; DeJesus E; Berthon-Jones N; Espinosa N; Courtney-Vega K; Absar N; Haskelberg H; Robson R; Donaldson A; Guelman D; Gambardella L; Valdovinos M; Arnaiz J; Beleta H; Ramos N; Targa M; Späth B; Boesecke C; Engelhardt A; Perry N; Beckthold B; Drummond F; Lefevre E; Corr S; Grant C; Lupo S; Peroni L; Sanchez M; De Paz Sierra M; Viloria G; Parlante A; Bissio E; Luchetti P; Confalonieri V; Warley E; Vieni I; Vilas C; Zarate A; Mayer G; Elliot J; Hagenauer M; Kelley M, 2018, 'Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study', HIV Medicine, vol. 19, pp. 65 - 71, http://dx.doi.org/10.1111/hiv.12532
2018
Martinello M; Bhagani S; Gane E; Orkin C; Cooke G; Dore GJ; Petoumenos K; Applegate TL; Tu E; Marks P; Pagani N; Grebely J; Nelson M; Matthews GV, 2018, 'Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection', Journal of Viral Hepatitis, vol. 25, pp. 1180 - 1188, http://dx.doi.org/10.1111/jvh.12917
2018
Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Fisher M; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Arnaiz JA; Cooper D; Rockstroh JK; Mallon P; Emery S, 2016, 'Maraviroc, as a switch option, in HIV-1-infected individuals with stable, well-controlled HIV replication and R5-tropic virus on their first Nucleoside/Nucleotide reverse transcriptase inhibitor plus ritonavir-boosted protease inhibitor regimen: Week 48 Results of the randomized, multicenter March study', Clinical Infectious Diseases, vol. 63, pp. 122 - 132, http://dx.doi.org/10.1093/cid/ciw207
2016
Tu E; Swenson LC; Land S; Pett S; Emery S; Marks K; Kelleher AD; Kaye S; Kaiser R; Schuelter E; Harrigan R, 2013, 'Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc switch collaborative study', Journal of Clinical Microbiology, vol. 51, pp. 2063 - 2071, http://dx.doi.org/10.1128/JCM.00510-13
2013
Baleriola C; Tu E; Johal H; Gillis J; Ison M; Law MG; Coghlan P; Rawlinson W, 2012, 'Organ donor screening using parallel nucleic acid testing allows assessment of transmission risk and assay results in real time.', Transplant Infectious Disease, vol. 14, pp. 278 - 287, http://dx.doi.org/10.1111/j.1399-3062.2012.00734.x
2012
Nguyen O; Sheppeard V; Douglas MW; Tu E; Rawlinson W, 2010, 'Acute hepatitis C infection with evidence of heterosexual transmission', Journal of Clinical Virology, vol. 49, pp. 65 - 68, http://dx.doi.org/10.1016/j.jcv.2010.06.008
2010
Kainer G, 2010, 'Influenze B Virus Transmission in Receipients of Kidney and Lung Transplants From an Infected Donor', Transplantation, vol. 90, pp. 99 - 102, http://dx.doi.org/10.1097/TP.0b013e3181da1933
2010
Eden J-S; Bull RA; Tu ET; McIver CJ; Michael JL; John AM; David WS; Jennie M; Rawlinson WD; White PA, 2010, 'Norovirus GII.4 variant 2006b caused epidemics of acute gastroenteritis in Australia during 2007 and 2008', Journal of Clinical Virology, vol. 49, pp. 265 - 271, http://dx.doi.org/10.1016/j.jcv.2010.09.001
2010
Tu ET; Bull RA; Kim M; Mciver CJ; Heron LG; Rawlinson WD; White PA, 2008, 'Norovirus excretion in an aged-care setting', Journal of Clinical Microbiology, vol. 46, pp. 2119 - 2121, http://dx.doi.org/10.1128/JCM.02198-07
2008
Tu ET; Bull RA; Greening G; Hewitt JE; Lyon M; Marshall J; Rawlinson WD; White PA, 2008, 'Epidemics of gastroenteritis during 2006 were associated with the spread of norovirus GII.4 variants 2006a and 2006b', Clinical Infectious Diseases, vol. 46, pp. 413 - 420, http://dx.doi.org/10.1086/525259
2008
Tu ET; Nguyen TV; Lee PJ; Bull RA; Musto JA; Hansman G; White PA; Rawlinson WD; Mciver CJ, 2007, 'Norovirus GII.4 strains and outbreaks, Australia', Emerging Infectious Diseases, vol. 13, pp. 1128 - 1130, http://dx.doi.org/10.3201/eid1307.060999
2007
Bull RA; Tu ET; Mciver CJ; Rawlinson WD; White PA, 2006, 'Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis', Journal of Clinical Microbiology, vol. 44, pp. 327 - 333, http://dx.doi.org/10.1128/JCM.44.2.327-333.2006
2006
Hansman G; Takeda N; Katayama K; Tu ET; Mciver CJ; Rawlinson WD; White PA, 2006, 'Genetic diversity of sapovirus in children, Australia', Emerging Infectious Diseases, vol. 12, pp. 141 - 143, http://dx.doi.org/10.3201/eid1201.050846
2006
Conference Papers
add
Land S; Tu E; Swenson L; Kelleher A; Kaye S; Pett SL; Emery S; Kaiser R; Silk D; Berthon-Jones N; Harrigan PR, 2013, 'Proviral DNA testing of HIV tropism in the Maraviroc Switch Collaborative Study (MARCH) - results of a three-phase quality assurance (QA) programme', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Toronto, CANADA, pp. A144 - A144, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, Toronto, CANADA, 04 June 2013 - 08 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335229500117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Reports
add
Tu E; Swenson LC; Land S; Pett S; Emery S; Marks K; Kelleher AD; Kaye S; Kaiser R; Schuelter E; Harrigan R, 2013, Reply to "issues on results of the external quality assessment for proviral DNA testing of HIV-1 tropism in the maraviroc switch collaborative study", http://dx.doi.org/10.1128/JCM.02207-13
2013
Book Chapters
add
Mciver CJ; Bull RA; Tu ET; Rawlinson WD; White PA, 2005, 'Norovirus and Sapovirus', in McIver CJ (ed.), A Compendium of Laboratory Diagnostic Methods for Common and Unusual Enteric Pathogens - an Australian Perspective, edn. 1, Australian Society of Microbiology, Australia, pp. 191 - 198
2005